Eye Care Professionals

12/28/2025

5 key features a long-term disability policy should include https://www.aoa.org//news/practice-management/perfect-your-practice/5-key-features-a-long-term-disability-policy-should-include

12/27/2025

Doctors questioning Superior Vision auto-enrollment with Davis Vision https://www.aoa.org//news/advocacy/third-party/superior-vision-auto-enrollment-with-davis-vision

12/26/2025

Many Patients Experience Visual Improvement After Limbal Stem Cell Transplantation

A retrospective study noted significant visual improvements in many eyes with limbal stem cell deficiency after limbal stem cell transplantation, especially in eyes with certain etiologies.

12/25/2025

Intravitreal Ceftazidime Could Possibly Be Used in the Short Term for Syphilitic Uveitis

When antibiotics are not immediately available to treat syphilitic uveitis, intravitreal ceftazidime may be a potential short-term stopgap measure.

12/24/2025

Paraoptometric associates create caring first impressions for eye care https://www.aoa.org//news/inside-optometry/member-spotlight/paraoptometric-associates-create-caring-first-impressions-for-eye-care

12/23/2025

AI scans accurately detect diabetic eye disease in Australian trial https://medicalxpress.com/news/2025-09-ai-scans-accurately-diabetic-eye.html

A new Australian study has found that an automated AI camera can accurately detect diabetic eye disease with more than 93% accuracy in non-eye care settings.

12/22/2025

Weekly Journal Update — September 3, 2025

Retinoblastoma signs and disease stage, glaucoma medication-identification for patients, risk factors for endophthalmitis after PPV, Vitamin D and keratoconus, biometric indicators of long-term angle-

12/21/2025

In Some Patients With TED, Teprotumumab May Reduce Orbital Muscle and Fat Volume

Patients with thyroid eye disease (TED) who have high pre-treatment proptosis and orbital muscle volume may benefit more from teprotumumab treatment than other patients with TED.

12/20/2025

Trend Toward Globe-Sparing Treatments for Retinoblastoma in the United States

Rates of enucleation for retinoblastoma appear to have decreased in the US from 2004 to 2016, though these trends were not equally distributed among all patient groups.

12/19/2025

Retinitis pigmentosa mouse models reflect pathobiology of human RP59 https://medicalxpress.com/news/2025-08-retinitis-pigmentosa-mouse-pathobiology-human.html

Retinitis pigmentosa retinal degeneration is caused by a family of hereditary mutations in nearly 100 genes that slowly lead to blindness over years or decades.

12/18/2025

Week in Review: Pregnancy and Severe Diabetic Retinopathy, Role of Visual Defects in Auto Accidents

Women with type 1 diabetes may not incur an additional risk of severe diabetic retinopathy either during or after pregnancy, and people with visual defects could be more likely to have motor vehicle a

12/17/2025

Injectable obesity medications associated with reduced risk for eye inflammation https://medicalxpress.com/news/2025-08-obesity-medications-eye-inflammation.html

Cleveland Clinic Cole Eye Institute researchers have identified a potential association between the use of GLP-1 receptor agonist (GLP-1RA) therapy and a reduced risk of non-infectious uveitis, a type of eye inflammation.